Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer
Taraswi Mitra Ghosh, Jason White, Joshua Davis, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 9

Showing 9 citing articles:

Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach
Ilaria Granata, Paola Barboro
Biomolecules (2024) Vol. 14, Iss. 1, pp. 87-87
Open Access | Times Cited: 3
Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside
Antonio Giovanni Solimando, Charis Kalogirou, Markus Krebs
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial–mesenchymal Transition in Aggressive Variant Prostate Cancers
Taraswi Mitra Ghosh, Suman Mazumder, Joshua Davis, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 7, pp. 1286-1311
Open Access | Times Cited: 5
Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance
Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 180-180
Open Access | Times Cited: 5
The Andrographolide Analogue 3A.1 Synergizes with Taxane Derivatives in Aggressive Metastatic Prostate Cancers by Upregulation of Heat Shock Proteins and Downregulation of MAT2A-Mediated Cell Migration and Invasion
Taraswi Mitra Ghosh, Teeratas Kansom, Suman Mazumder, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 380, Iss. 3, pp. 180-201
Open Access | Times Cited: 7
Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial–Mesenchymal Transition
Joshua Davis, Taraswi Mitra Ghosh, Suman Mazumder, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8490-8490
Open Access | Times Cited: 2
Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach
Ilaria Granata, Paola Barboro
(2023)
Open Access | Times Cited: 1
Topotecan inhibits metastasis of non-small cell lung cancer by regulating epithelial-mesenchymal transition
Zhen Liu, Lvqian Guo, Panpan Yin, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 5, pp. 100051-100051
Open Access | Times Cited: 1
Precision medicine: Overview and challenges to clinical implementation
Susanne B. Haga
Elsevier eBooks (2023), pp. 513-529
Closed Access
Page 1

Scroll to top